Genetic polymorphisms and immunologic profiles in arteriogenesis

Genetic polymorphisms and immunologic profiles in arteriogenesis - GLACIER study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON44569

Enrollment

Registered

2015-06-09

Start date

2015-06-12

Completion date

Unknown

Last updated

2024-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstructive coronary artery disease and collateral artery growth

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: >18 years old present chronic total occlusion of one of the coronaries Patients who undergo succesfull PCI

Exclusion criteria

Exclusion criteria: -refusal or inabilty to give informed consent -Age >80 -Immunologic disorder of disease, recent use of immunosuppressive drugs. -haemodynamic unstablility

Design outcomes

Primary

Measure	Time frame
Main study endpoints: the main study endpoints are collateral flow, as determined by CFI, arteriogenic polymorphism, determined by DNA-profile and immunologic phenotype.	—

Secondary

Measure	Time frame
Heart function	—

Countries

Netherlands

Outcome results